Estimating the economic costs of antimicrobial resistance : model and results

[thumbnail of RAND_RR911.pdf] PDF
RAND_RR911.pdf - Draft Version
Embargoed item. Restricted access to Repository staff only - Requires a PDF viewer.
Download (1MB)

Request Changes to record.

Abstract

Antimicrobial resistance (AMR) has increasingly been recognised as a growing global health threat (WHO, 2012), and the urgency of the AMR situation is now well accepted by many policy-makers, scientists, as well as by civil society organisations, including patients’ advocacy groups. Despite growing awareness and concern, inertia appears to persist in improving stewardship of existing antimicrobials to prevent a future with more resistant bacteria (Dowling et al., 2013). For instance, in comparison with climate change, while there appears to be increasing scientific consensus about the urgency of countering the impact of global warming, this is perhaps less clear (or at least the emerging consensus is less coherent) for antimicrobial resistance.

Item Type: Report
Subjects: Q Science > QR Microbiology
R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine
Divisions: Faculty of Social Sciences > Institute for Employment Research
Library of Congress Subject Headings (LCSH): Drug resistance in microorganisms, Medical economics, Medical care, Public health, Epidemiology
Series Name: Research Reports
Publisher: RAND Corporation
Official Date: 2014
Dates:
Date
Event
2014
Available
Number: RR-911-WT
Number of Pages: 113
Status: Not Peer Reviewed
Access rights to Published version: Restricted or Subscription Access
Copyright Holders: The Wellcome Trust
Funder: Wellcome Trust (London, England)
Related URLs:
URI: https://wrap.warwick.ac.uk/70628/

Export / Share Citation


Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item